Guardant Health (GH) CIO Kumud Kalia sells 5,000 shares in open market

Rhea-AI Filing Summary

Guardant Health, Inc. Chief Information Officer Kumud Kalia reported an open-market sale of 5,000 shares of Common Stock. The shares were sold at a price of $130.406 per share. After this transaction, Kalia directly owns 44,508 shares, indicating a remaining substantial equity position.

Insider Trade Summary

Net Seller: 5,000 shares ($652,030)

Net Sell 1 txn

Insider Kalia Kumud

Role Chief Information Officer

Sold 5,000 shs ($652K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$130.406	$652K

Holdings After Transaction: Common Stock — 44,508 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 5,000 shares Sale price: $130.406 per share Shares held after sale: 44,508 shares +1 more

4 metrics

Shares sold 5,000 shares Open-market sale of Common Stock on 2026-06-10

Sale price $130.406 per share Execution price for 5,000 shares sold

Shares held after sale 44,508 shares Direct ownership following the reported transaction

Transaction code S Indicates open-market or private sale of non-derivative Common Stock

Key Terms

open-market sale, Common Stock, Form 4

3 terms

open-market sale financial

"the transaction_action field describes this as an open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"the security_title is listed as Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"the transaction is reported on a Form 4 insider filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalia Kumud

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		S		5,000	D	$130.406	44,508	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Table I includes 259 shares acquired under Guardant Health's Employee Stock Purchase Plan on 5/14/2026.

	/s/ John G. Saia, as attorney-in-fact for Kumud Kalia	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Guardant Health (GH) disclose for Kumud Kalia?

Guardant Health reported that Chief Information Officer Kumud Kalia executed an open-market sale of 5,000 shares of Common Stock. The transaction is disclosed on a Form 4 insider filing, detailing the share amount, sale price, and post-transaction holdings.

At what price did Kumud Kalia sell Guardant Health (GH) shares?

Kumud Kalia sold 5,000 Guardant Health Common Stock shares at $130.406 per share. This price reflects the execution level for the open-market sale reported in the Form 4, providing transparency into the insider’s transaction terms.

How many Guardant Health (GH) shares does Kumud Kalia hold after the sale?

After selling 5,000 shares, Kumud Kalia directly owns 44,508 Guardant Health Common Stock shares. This remaining stake, disclosed in the Form 4, shows that the insider continues to maintain a significant equity position in the company.

Was Kumud Kalia’s Guardant Health (GH) trade a buy or a sell?

The Form 4 lists the transaction under code “S,” meaning an open-market sale. Kumud Kalia disposed of 5,000 shares of Guardant Health Common Stock rather than acquiring additional shares in this reported transaction.

What role does Kumud Kalia hold at Guardant Health (GH)?

Kumud Kalia serves as Chief Information Officer at Guardant Health. His position as an executive officer makes his equity transactions subject to Form 4 reporting requirements, providing investors with timely visibility into his trading activity in company stock.